Pre-clinical markers for diagnosis of diabetic nephropathy in patients with type 1 diabetes mellitus

被引：0
作者：
Lebedeva, N. O. [1 ]
Vikulova, O. K. [1 ]
机构：
[1] Endocrinol Res Ctr, Moscow, Russia
来源：
DIABETES MELLITUS | 2012年 / 15卷 / 02期
关键词：
diabetic nephropathy; diabetes mellitus type 1; pre-clinical diagnostics; proteomic analysis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Due to progressive nature of diabetic nephropathy (DN) and limited effectiveness of therapeutic efforts at clinically overt stages, diagnosis of pre-clinical (and, therefore, potentially reversible) DN is especially important. To date, however, test for microalbuminuria remains the only technique applicable for early diagnostics of DN. Current review addresses search for potential markers of pre-clinical stage of DN in patients with type 1 diabetes mellitus and embraces data from latest experimental and clinical studies in this area.
引用
收藏
页码：38 / 45
页数：8
相关论文
共 50 条
  • [31] Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus
    Metwalley, Kotb Abbass
    Farghaly, Hekma Saad
    Gabri, Magda Farghali
    Abdel-Aziz, Safwat Mohamed
    Ismail, Asmaa Mohamed
    Raafat, Duaa Mohamed
    Elnakeeb, Islam Fathy
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2021, 13 (03) : 293 - 299
  • [32] Sirtuin 1 rs7069102 polymorphism is associated with diabetic nephropathy in patients with type 2 diabetes mellitus
    Letonja, Jernej
    Zavrsnik, Matej
    Makuc, Jana
    Seruga, Maja
    Peterlin, Ana
    Cilensek, Ines
    Petrovic, Danijel
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (05) : 642 - 646
  • [33] Dyslipidaemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy
    Martínez-Castelao, A
    Ramos, R
    González, MT
    Castiñeiras, MJ
    NEFROLOGIA, 2002, 22 : 51 - 58
  • [34] Aldose reductase gene polymorphism is associated with progression of diabetic nephropathy in Japanese patients with type 1 diabetes mellitus
    Yamamoto, T
    Sato, T
    Hosoi, M
    Yoshioka, K
    Tanaka, S
    Tahara, H
    Nishizawa, Y
    Fujii, S
    DIABETES OBESITY & METABOLISM, 2003, 5 (01) : 51 - 57
  • [35] Role of ENPP1 Gene Variants in the Susceptibility to Diabetic Nephropathy in Patients with type 2 Diabetes Mellitus
    Faraji, Niloofar
    Abbaspour, Saima
    Ajamian, Farzam
    Keshavarz, Parvaneh
    BIOCHEMICAL GENETICS, 2023, 61 (06) : 2710 - 2723
  • [36] Role of ENPP1 Gene Variants in the Susceptibility to Diabetic Nephropathy in Patients with type 2 Diabetes Mellitus
    Niloofar Faraji
    Saima Abbaspour
    Farzam Ajamian
    Parvaneh Keshavarz
    Biochemical Genetics, 2023, 61 : 2710 - 2723
  • [37] A Search for Association between the Polymorphic Markers of PON1 and PON2 Genes and Diabetic Nephropathy in Patients with Type I Diabetes Mellitus
    O. E. Voron’ko
    N. Yu. Yakunina
    M. V. Shestakova
    E. V. Zotova
    L. A. Chugunova
    M. Sh. Shamkhalova
    O. K. Vikulova
    V. G. Debabov
    I. I. Dedov
    V. V. Nosikov
    Russian Journal of Genetics, 2005, 41 : 688 - 692
  • [38] Serum cathelicidin as a marker for diabetic nephropathy in patients with type 1 diabetes
    El-Ashmawy, Hazem M.
    Ahmed, Azza M.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (08)
  • [39] Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes
    Fyhrquist, F.
    Tiitu, A.
    Saijonmaa, O.
    Forsblom, C.
    Groop, P. -H.
    JOURNAL OF INTERNAL MEDICINE, 2010, 267 (03) : 278 - 286
  • [40] Clinical and pharmacological factors related to the requirements of laser photocoagulation in patients with diabetic nephropathy due to type 2 diabetes mellitus
    Auyanet, Ingrid
    Jose Rodriguez, Luis
    Yurena Sanchez, Ana
    Esparza, Noemi
    Cabrera, Francisco
    Bosch, Elvira
    Cardona, Pedro
    Dolores Checa, Maria
    MEDICINA CLINICA, 2011, 137 (04): : 152 - 156
12345